Financial Services Advisory’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Financial Services Advisory’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Buy	+3,829	New	+$518K	0.15%	53
2026 Q1	–	Sell	-6,984	Closed	-$852K	–	77
2025 Q4	$852K	Buy	+6,984	New	+$801K	0.31%	41
2023 Q3	–	Sell	-9,610	Closed	-$800K	–	57
2023 Q2	$800K	Buy	+9,610	New	+$804K	0.33%	31

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Financial Services Advisory's XBI Position: Q2 2026 in Review

Financial Services Advisory opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 3,829 shares worth $606K. The stake represents 0.15% of the portfolio and ranks #53 among its holdings. This is a return to the name: Financial Services Advisory previously reported a position in XBI as recently as Q4 2025.

Financial Services Advisory first reported a position in XBI in Q2 2023 and has held it in 3 quarters since. The position peaked at $852K in Q4 2025. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Financial Services Advisory held 3,829 shares of State Street SPDR S&P Biotech ETF worth $606K as of Q2 2026.
State Street SPDR S&P Biotech ETF was a new Financial Services Advisory position in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.15% of Financial Services Advisory's portfolio in Q2 2026, its #53 holding.
Financial Services Advisory first reported a position in State Street SPDR S&P Biotech ETF in Q2 2023 and has held it in 3 quarters since.
Financial Services Advisory's State Street SPDR S&P Biotech ETF position peaked at $852K in Q4 2025.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Financial Services Advisory's 13F filing for Q2 2026, filed 3 Aug 2026.